LMS Compliance Ltd

LMS Compliance Ltd. (the “Company”) is a laboratory group with an established track record and strong market reputation. The Group has 3 accredited laboratories and 1 sales office across Malaysia, providing quality testing and certification services for customers across a gamut of industries, ranging from food, feed, fertilizer, pharmaceutical, medical devices, healthcare, industrial and Greentech.

For more information, please visit HTTP://lmscompliance.com/


  • Established track record and strong market reputation
    • The Group has more than 15 years of experience in laboratory testing and/or certification services. As a result, the Group has cultivated lasting relationships with many of its customers – from FY2019 to FY2021, more than 80% of the Group’s revenue from its testing and assessment segment was derived from repeat customers 
  • Experienced and competent management team
    • The founders of the Group, CEO, Dr. Ooi, and Chief Development Officer, Ms. Chong, have over 13 years and 22 years of experience respectively in the testing and/or certification industry. The Group’s Chairman of the Board, Datuk Fadilah Baharin, served as DirectorGeneral of the Department of Standards Malaysia from 2006 to 2020 and was a member of the ISO Council from 2017 to 2019. 
  • Diverse range of services and locations caters to the wide-ranging needs of its customers

  • Strong technical expertise gives the Group a market advantage
    • As at 16 September 2022, the Group has the capability to conduct 1,100+ accredited tests and 10,200+ non-accredited tests.
  • Constant innovation and digitalization of the Group’s work processes and systems
    • In 2020, the Group began licensing aikinz-LIMS to third-party laboratories and also launched its cloud-based automated workflow ISO certification platform, aizenz, which seeks to streamline ISO certification processes and improve audit readiness for such certification processes. The Group aims to augment its revenue streams as it continues to enhance its aikinz-LIMS and aizenz applications.

The Directors intend to recommend and distribute dividends of a minimum of 20% of the Group’s profit attributable to owners of the Company in respect of FY2022, FY2023 and FY2024.


Brokerages Report Analysts Recommendation TP

Download File 

Singapore Research Non-rated



16 December 2022  – UOBKH: LMS Compliance – the future of laboratory testing

Stock Information
Price S$0.27
Market Cap  S$23.6m
Free Float 16.0%
YE 31 Dec
Key financial highlights
Key Highlights FY2020 FY2021 FY2022
Revenue (RM ‘m) 15.8 17.0 18.7
EBITDA (RM ‘m) 7.3 7.8 3.7
EBITDA Margin 46.4% 45.7% 19.8%
Adjusted Net Profit (RM ‘m) 4.7 4.9 5.1*

*Excludes one off listing expenses of RM 4.4 million